Literature DB >> 6467164

Non-Hodgkin's lymphomas. Application of the International Classification of Diseases for Oncology (ICD-O) to the Working Formulation.

C Percy, G O'Conor, L G Ries, E S Jaffe.   

Abstract

International Classification of Diseases for Oncology (ICD-O) code numbers for the non-Hodgkin's lymphomas (NHL) are assigned to the new Working Formulation (WF). This will facilitate the coding of NHL cases by registrars and pathologists by providing a ready means of translation of terms utilized in most of the existing classification schemes. Additional code numbers and synonyms are suggested to accommodate all of the terms in the six major classification systems currently in use and to permit the coding of immunologic cell type when appropriate tests have been performed. To demonstrate how the assignment of these code numbers can be useful, over 8000 incidence cases from the Surveillance, Epidemiology and End Results (SEER) Program (1977-1980) were coded according to the WF groups and the data analyzed. The prognostic significance of the three major groups in the WF is confirmed for each group in the SEER data and comparisons are discussed with the NCI study.

Entities:  

Mesh:

Year:  1984        PMID: 6467164     DOI: 10.1002/1097-0142(19841001)54:7<1435::aid-cncr2820540734>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma.

Authors:  L M Brown; G D Everett; R Gibson; L F Burmeister; L M Schuman; A Blair
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

2.  Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.

Authors:  Varun R Kshettry; Quinn T Ostrom; Carol Kruchko; Ossama Al-Mefty; Gene H Barnett; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

3.  The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants.

Authors:  L J Herrinton; M Goldoft; S M Schwartz; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

4.  Nut Consumption and Lung Cancer Risk: Results from Two Large Observational Studies.

Authors:  Jennifer T Lee; Gabriel Y Lai; Linda M Liao; Amy F Subar; Pier Alberto Bertazzi; Angela C Pesatori; Neal D Freedman; Maria Teresa Landi; Tram Kim Lam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-11       Impact factor: 4.254

5.  Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Sam M Mbulaiteye; Lindsay M Morton; Joshua N Sampson; Ellen T Chang; Laura Costas; Silvia de Sanjosé; Tracy Lightfoot; Jennifer Kelly; Jonathan W Friedberg; Wendy Cozen; Rafael Marcos-Gragera; Susan L Slager; Brenda M Birmann; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

6.  Occupational risk factors for selected cancers among African American and White men in the United States.

Authors:  Nathaniel C Briggs; Robert S Levine; H Irene Hall; Otis Cosby; Edward A Brann; Charles H Hennekens
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

7.  The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.

Authors:  R F Carter; V E Valli; J H Lumsden
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310

8.  Low-carbohydrate, high-protein diet score and risk of incident cancer; a prospective cohort study.

Authors:  Lena Maria Nilsson; Anna Winkvist; Ingegerd Johansson; Bernt Lindahl; Göran Hallmans; Per Lenner; Bethany Van Guelpen
Journal:  Nutr J       Date:  2013-05-07       Impact factor: 3.271

9.  Lenalidomide in diffuse large B-cell lymphoma.

Authors:  Catherine Thieblemont; Marie-Hélène Delfau-Larue; Bertrand Coiffier
Journal:  Adv Hematol       Date:  2012-11-20

10.  Survival from non-Hodgkin lymphoma in England and Wales up to 2001.

Authors:  B Rachet; E Mitry; A Shah; N Cooper; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.